Federal Register / Vol. 87, No. 38 / Friday, February 25, 2022 / Notices 10771 

representative samples using 

transparent methodology. The BTOS 

will produce data continuously, in part 

as a response to feedback on the SBPS 

that longer time series would have been 

useful to contextualize the pandemic 

impact. Continuous data will allow for 

the measurement of economic trends 

during all phases of the business cycle 

as well as during times of economic and 

other emergencies. The BTOS will 

uniquely provide the ability to produce 

these data and associated measures of 

quality. 

The BTOS data series will provide 

insight on the state of the economy, 

prior to and during an event (including 

but not limited to natural disasters or 

economic crises) and will assist in 

monitoring the recovery from the event. 

It will also be useful in understanding 

aggregate and subaggregate changes in 

economic trends throughout the 

business cycle. BTOS data may be used 

by elected officials, government 

program officials, policy makers, 

industry leaders, economic and social 

analysts, business entrepreneurs, 

business and economic news 

organizations, and domestic and foreign 

researchers in academia, business, and 

government. 

The BTOS will allow for a large 

number of data products that are 

complementary to the Census Bureau’s 

existing monthly and quarterly 

economic indicator programs which 

provide estimates of contemporaneous 

economic activity at the national sector 

level. The BTOS will produce 

complementary disaggregate 

contemporaneous data as well as data 

that reflect the outlook of businesses. 

The BTOS will be complementary to the 

Census Bureau’s existing annual 

programs, serving as a platform through 

which trends and data gaps may first be 

identified for subsequent inclusion in 

annual programs. 

The BTOS instrument will include 

core and supplemental content. Core 

content will form the basis of the 

instrument and run continuously; core 

content will include measures of 

economic activity that are applicable 

across all non-farm sectors and are 

important across the business cycle and 

during economic or other emergencies. 

Supplemental content will be included 

on the instrument with a regular 

periodicity and will be designed to 

provide urgently needed data on an 

emerging or current issue. 

Core concepts for the BTOS will be 

selected based on research and analysis 

conducted during the SBPS, stakeholder 

feedback, and the ability to collect 

complementary items on monthly, 

quarterly, annual, or census programs to 

provide context and benchmarking. 

Initially, all data products will be 

accessible through the Census Bureau’s 

Experimental Data Products site. 

Experimental data products are clearly 

identified and include methodology and 

supporting research with their release. 

Affected Public: Business or other forprofit organizations. 

Frequency: Bi-weekly. 

Respondent’s Obligation: Voluntary. 

Legal Authority: Title 13 U.S.C., 

Sections 131 and 182. 

This information collection request 

may be viewed at www.reginfo.gov. 

Follow the instructions to view the 

Department of Commerce collections 

currently under review by OMB. 

Written comments and 

recommendations for the proposed 

information collection should be 

submitted within 30 days of the 

publication of this notice on the 

following website www.reginfo.gov/ 

public/do/PRAMain. Find this 

particular information collection by 

selecting ‘‘Currently under 30-day 

Review—Open for Public Comments’’ or 

by using the search function and 

entering the title of the collection. 

Sheleen Dumas, 

Department PRA Clearance Officer, Office of 

the Chief Information Officer, Commerce 

Department. 

[FR Doc. 2022–04060 Filed 2–24–22; 8:45 am] 

BILLING CODE 3510–07–P 

DEPARTMENT OF COMMERCE 

Foreign-Trade Zones Board 

[B–05–2022] 

Foreign-Trade Zone (FTZ) 99— 

Wilmington, Delaware, Notification of 

Proposed Production Activity 

AstraZeneca Pharmaceuticals, LP 

(Pharmaceutical Products), Newark, 

Delaware 

AstraZeneca Pharmaceuticals, LP 

submitted a notification of proposed 

production activity to the FTZ Board 

(the Board) for its facility in Newark, 

Delaware within Subzone 99D. The 

notification conforming to the 

requirements of the Board’s regulations 

(15 CFR 400.22) was received on 

February 16, 2022. 

Pursuant to 15 CFR 400.14(b), FTZ 

production activity would be limited to 

the specific foreign-status materials and 

specific finished products described in 

the submitted notification (summarized 

below) and subsequently authorized by 

the Board. The benefits that may stem 

from conducting production activity 

under FTZ procedures are explained in 

the background section of the Board’s 

website—accessible via www.trade.gov/ 

ftz. The proposed finished products and 

materials would be added to the 

production authority that the Board 

previously approved for the operation, 

as reflected on the Board’s website. 

The proposed finished products 

include: BRILINTA (ticagrelor) tablets; 

LYNPARZA (olaparib) tablets; 

SEROQUEL IR (quetiapine fumarate) 

tablets; and, SEROQUEL XR (quetiapine 

fumarate) tablets (duty-free). 

The proposed foreign-status materials 

include: Anastrozole active 

pharmaceutical ingredient (API); 

olaparib API; quetiapine fumarate API; 

and, ticagrelor API (duty rates 6.5%). 

The request indicates that olaparib API 

and ticagrelor API are subject to duties 

under Section 301 of the Trade Act of 

1974 (Section 301), depending on the 

country of origin. The applicable 

Section 301 decisions require subject 

merchandise to be admitted to FTZs in 

privileged foreign status (19 CFR 

146.41). 

Public comment is invited from 

interested parties. Submissions shall be 

addressed to the Board’s Executive 

Secretary and sent to: ftz@trade.gov. The 

closing period for their receipt is April 

6, 2022. 

A copy of the notification will be 

available for public inspection in the 

‘‘Online FTZ Information System’’ 

section of the Board’s website. 

For further information, contact 

Christopher Wedderburn at 

Chris.Wedderburn@trade.gov. 

Dated: February 18, 2022. 

Andrew McGilvray, 

Executive Secretary. 

[FR Doc. 2022–03953 Filed 2–24–22; 8:45 am] 

BILLING CODE 3510–DS–P 

DEPARTMENT OF COMMERCE 

Bureau of Industry and Security 

Transportation and Related Equipment 

Technical Advisory Committee; Notice 

of Partially Closed Meeting 

The Transportation and Related 

Equipment Technical Advisory 

Committee will meet on March 16, 

2022, at 11:30 a.m., Eastern Standard 

Time, via teleconference. The 

Committee advises the Office of the 

Assistant Secretary for Export 

Administration with respect to technical 

questions that affect the level of export 

controls applicable to transportation 

and related equipment or technology. 


lotter on DSK11XQN23PROD with NOTICES1